About Regional Health Clinical Research
"Monument Health Rapid City Hospital is the region's leading medical center offering a broad scope of services to keep you and your family healthy. We provide health care services to the 360,000 people who live in the Black Hills of South Dakota and the surrounding areas, as well as thousands of visitors each year."
Clinical Trials at Regional Health Clinical Research
During the past decade, Regional Health Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Health Clinical Research"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Regional Health Clinical Research
According to Clinical.Site data, the most researched conditions in "Regional Health Clinical Research" are
"Rheumatoid Arthritis" (3 trials), "Arthritis" (1 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials) and "End Stage Renal Disease" (1 trials). Many other conditions were trialed in "Regional Health Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Regional Health Clinical Research
Most popular intervention types in "Regional Health Clinical Research" are "Biological" (4 trials) and "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab" (1 trials), "Empagliflozin" (1 trials), "GP2013" (1 trials), "Infliximab" (1 trials) and "MabThera" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Regional Health Clinical Research
The vast majority of trials in "Regional Health Clinical Research" are
6 trials for "All" genders.
Clinical Trials Status at Regional Health Clinical Research
Currently, there are NaN active trials in "Regional Health Clinical Research".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Regional Health Clinical Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Regional Health Clinical Research, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".